Inulin hydrogels. II. In vitro degradation study
Introduction
Targeting of drugs to the colon is considered to have several therapeutic advantages (Rubinstein, 1990, Ashford and Fell, 1994, Van den Mooter and Kinget, 1995): (1) By treating colonic disorders such as ulcerative colitis, Crohn's disease, colon carcinoma's and infections with a site-specific delivery system, therapy will be more effective, the required dose can be lowered and undesirable side effects can be reduced. (2) For drugs such as peptides and proteins, which are destroyed by the stomach acid and/or metabolised by enzymes of the small intestine, colon targeting can be a valuable alternative for parenteral administration, due to negligible activity of brush-border peptidase activity and much less activity of pancreatic enzymes in the colon in comparison to the small intestine. (3) colonic release of drugs can also be valuable when a delay in absorption is desired from a therapeutic point of view in the treatment of diseases that have peak symptoms in the early morning, such as nocturnal asthma, angina or arthritis.
Inulin hydrogels have been developed as potential new carriers for colonic drug targeting. Inulin is a naturally occurring polysaccharide (Van Loo et al., 1995) which consists of β 2–1 linked d-fructose molecules. Most of the fructose chains have a glucosyl unit at the reducing end (Roberfroid, 1993). Inulin was chosen as candidate polymer for the development of colon-specific hydrogels because the β 2–1 osidic bonds are not significantly hydrolysed by enzymes from the endogenous secretion of the human digestive tract (Dysseler and Hoffem, 1995); colonic bacteria however, and more specifically Bifidobacteria which constitute up to 25% of the normal gut flora in man (McKellar and Modler, 1989), are able to ferment inulin (Wang and Gibson, 1993, Gibson and Roberfroid, 1995).
In vitro degradation of inulin suspended in Eudragit® RS films was already demonstrated in previous work (Vervoort and Kinget, 1996); in order to prepare inulin hydrogels, the fructose polymer had to be derivatised which can affect its degradation properties. Development of inulin hydrogels has been previously described (Vervoort et al., 1997). Methacryloyl groups were incorporated in the inulin chains by reaction of the fructose polymer with glycidyl methacrylate and aqueous solutions of the resulting methacrylated inulin were subsequently converted into cross-linked hydrogels by free radical polymerisation.
The aim of this study was to investigate the enzymatic degradability of the prepared inulin hydrogels, a prerequisite for their use as colon-specific drug delivery systems. Degradation of the hydrogels in the colon will result in site-specific release of drug entrapped in the polymer network. The in vitro degradation study of the inulin hydrogels was performed by incubating the hydrogels in solutions of inulinase, able to hydrolyse the β 2–1 osidic linkages of the inulin chains. With respect to inulin hydrogel degradation, information was acquired on the effect of enzyme concentration, incubation time, degree of substitution and feed concentration of methacrylated inulin.
Section snippets
Materials
Chicory inulin (Raftiline HP; average degree of polymerisation between 22 and 25) was kindly provided by Orafti (Tienen, Belgium). N,N-dimethylformamide, ammonium persulfate (APS), sodium dihydrogen phosphate, dipotassium hydrogen phosphate and citric acid were supplied by UCB (Leuven, Belgium). Glycidyl methacrylate (96%) and isopropanol (anhydrous, 99+%) were purchased from Acros Organics (Geel, Belgium) and 4-dimethylaminopyridine, N,N,N′,N′-tetramethylethylenediamine (99%) (TMEDA) and
In vitro degradation study
In vitro degradation of inulin hydrogels was studied by incubation with Novozym 230, a commercial preparation containing endo- and exo-inulinase (obtained from Aspergillus niger) which can hydrolyse the β 2–1 fructosidic linkages of inulin, resulting in the release of free fructose. Degradation was monitored as a function of time by determining the percentage of free fructose vs the initial dry hydrogel weight (DS 8.1; feed concentration, 22% w/w) generated by various inulinase concentrations (
Conclusion
The data provided in this study indicate that despite derivatisation and cross-linking, inulin hydrogels can still be enzymatically degraded by inulinase. As expected, degradation was dependent on the incubation time and enzyme concentration. The enzymatic digestion of the inulin hydrogels also appeared to be dependent on the permeability of the hydrogel networks to inulinase: an increasing degree of substitution or feed concentration of MA-IN resulted in stronger hydrogels, attributed to an
Acknowledgements
We thank Orafti (Tienen, Belgium) for the generous gift of Raftiline HP, Novo Nordisk for donating Novozym 230 and Professor W.E. Hennink for co-operation concerning initiation in the derivatisation method of inulin.
References (20)
- et al.
In vitro degradation by colonic bacteria of inulin HP incorporated in Eudragit RS films
Int. J. Pharm.
(1996) - et al.
Site-specific drug delivery and penetration enhancement in the gastro-intestinal tract
J. Control. Release
(1995) - et al.
Targeting drugs to the colon: delivery systems for oral administration
J. Drug Target.
(1994) - et al.
Hydrogels for site-specific drug delivery to the colon: in vitro and in vivo degradation
Pharm. Res.
(1992) - et al.
Inulin, an alternative dietary fiber. Properties and quantitative analysis
Eur. J. Clin. Nutr.
(1995) - et al.
Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics
J. Nutr.
(1995) - et al.
Purification and characterisation of β-fructofuranosidase from Bifidobacterium infantis
Biol. Pharm. Bull.
(1994) - et al.
Theory of the increase in rigidity of rubbers during cure
J. Chem. Phys.
(1947) - et al.
Metabolism of fructo-oligosaccharides by Bifidobacterium spp
Appl. Microbiol. Biotechnol.
(1989) Quantitative determination of carbohydrates with Dreywood's anthrone reagent
Science
(1948)
Cited by (52)
Inulin-based carriers for colon drug targeting
2021, Journal of Drug Delivery Science and TechnologyCitation Excerpt :These two different scenarios showed that drug release from the carrier, not only depended on the inulin content but also depended on the drug loading techniques. Methacrylated inulin based hydrogel was developed for colon specific drug delivery [78,79]. They did a swelling study of that formulation and found that inulin hydrogel can absorb a huge amount of water and the mean swelling time of the formulation was within 0.44 h–1.12 h.
Inulin-based hydrogel
2021, Plant and Algal Hydrogels for Drug Delivery and Regenerative MedicineApplications of Polymers in Colon Drug Delivery
2020, Applications of Polymers in Drug DeliveryReview of polysaccharide particle-based functional drug delivery
2019, Carbohydrate PolymersCitation Excerpt :Inulin and pectin are polysaccharides that are not degraded by endogenous human enzymes, but are digested by the enzymes of bacteria in the gut, allowing them to be exploited for colon targeted delivery (Castelli et al., 2008; Pitarresi, Giacomazza, Triolo, Giammona, & Biagio, 2012; Sirisha & D'Souza, 2016; Vervoort, Rombaut, et al., 1998). Crosslinking inulin to form hydrogels does not prevent inulinase digestion (Vervoort et al., 1997), but varying crosslink density can be used to tune both enzyme diffusion into the hydrogel and enzyme affinity for the inulin chains, varying the degradation rate of the gel (Vervoort, Rombaut, et al., 1998). To prevent destructive swelling in the stomach of these inulin based hydrogels, they have included carboxylic acid groups in the crosslink chemistry, reducing premature drug release in the acidic conditions of the stomach, furthering the targeted delivery to the colon (Castelli et al., 2008).
Inulin as a multifaceted (active)substance and its chemical functionalization: From plant extraction to applications in pharmacy, cosmetics and food
2019, European Journal of Pharmaceutics and BiopharmaceuticsAmidated pectin/sodium carboxymethylcellulose microspheres as a new carrier for colonic drug targeting: Development and optimization by factorial design
2016, Carbohydrate PolymersCitation Excerpt :The colon is an attractive site for local and systemic delivery of conventional and labile drugs due to its unique features which include a near neutral pH, much longer transit time, reduced enzymatic activity and great response to absorption enhancers (Maestrelli, Cirri, Corti, Mennini, & Mura, 2008; Oliveira, Ferrari, Carvalho, & Evangelista, 2010; Sinha & Kumria, 2003). Typically, drugs which are destroyed by stomach acidity or metabolized by pancreatic enzymes are minimally affected in the colon (Vervoort, Rombaut, Van den Mooter, Augustijns, & Kinget, 1998). Further, drugs which suffer low oral bioavailability due to poor dissolution and metabolism in the gut wall, such as progesterone might enjoy enhanced bioavailability due to reduced colon enzymatic activity and enhanced dissolution achieved by the colon long transit time (Gadalla, Soliman, Mohammed, & El-Sayed, 2015).